These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 23094155

  • 1. Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism.
    Hofman-Bang J, Gravesen E, Olgaard K, Lewin E.
    Int J Nephrol; 2012; 2012():123576. PubMed ID: 23094155
    [Abstract] [Full Text] [Related]

  • 2. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K.
    J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
    [Abstract] [Full Text] [Related]

  • 3. Influence of parathyroid mass on the regulation of PTH secretion.
    Lewin E, Olgaard K.
    Kidney Int Suppl; 2006 Jul; (102):S16-21. PubMed ID: 16810305
    [Abstract] [Full Text] [Related]

  • 4. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 5. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T, Rastad J, Szabó E, Westin G, Akerström G.
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO.
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [Abstract] [Full Text] [Related]

  • 7. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
    Varshney S, Bhadada SK, Sachdeva N, Arya AK, Saikia UN, Behera A, Rao SD.
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol.
    Carrillo-López N, Alvarez-Hernández D, González-Suárez I, Román-García P, Valdivielso JM, Fernández-Martín JL, Cannata-Andía JB.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3479-84. PubMed ID: 18556746
    [Abstract] [Full Text] [Related]

  • 9. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function.
    Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ.
    J Bone Miner Res; 2002 Dec; 17(12):2206-13. PubMed ID: 12469914
    [Abstract] [Full Text] [Related]

  • 10. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
    Bas S, Aguilera-Tejero E, Bas A, Estepa JC, Lopez I, Madueño JA, Rodriguez M.
    J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
    [Abstract] [Full Text] [Related]

  • 11. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.
    Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y.
    J Clin Invest; 1993 Sep; 92(3):1436-43. PubMed ID: 8397225
    [Abstract] [Full Text] [Related]

  • 12. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
    Correa P, Akerstrom G, Westin G.
    Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
    [Abstract] [Full Text] [Related]

  • 13. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F, Finch JL, Denda M, Dusso AS, Brown AJ, Slatopolsky E.
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [Abstract] [Full Text] [Related]

  • 14. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
    McCann LM, Beto J.
    J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 19. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
    Lewin E, Garfia B, Almaden Y, Rodriguez M, Olgaard K.
    Kidney Int; 2003 Jul 01; 64(1):63-70. PubMed ID: 12787396
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of increased parathyroid hormone mRNA in experimental uremia: roles of protein RNA binding and RNA degradation.
    Yalcindag C, Silver J, Naveh-Many T.
    J Am Soc Nephrol; 1999 Dec 01; 10(12):2562-8. PubMed ID: 10589695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.